baber/WOPTO huggingface dataset:
Patent AU-2018318374-B2 (AU)
Title: Medical device and method of operating a medical device and detection of a short circuit
Inventor: FRIEDLI KURT
IPC: A61M5/168
Filed: 2018-08-15
Granted: 2021-03-11
Abstract: The invention concerns a medical device (10) designed for delivering a medical fluid or designed for controlling delivery of a medical fluid, and to a method of operating such a medical device. The medical device (10) comprises a user interface (12) associated with an electronic circuit (4) connected to a first port (31) and to a second port (31) of a controller (3). The electronic circuit (4) enables the controller (3) to detect actuation of the user interface (12). The controller is configured to execute the following sequence of steps: first step: configure (S4) the first port (31) as an output port and to apply (S5) a first signal to the first port; second step: to acquire (S6) a second signal from the second port (32); and third step: to determine (S8) on the basis of the second signal if a short circuit has occurred and to generate (S81) a short circuit alert signal if applicable.
Patent AU-2018334592-B2 (AU)
Title: Method and device for detecting active power of wind turbine
Inventor: YU MENGTING
IPC: F03D7/04
Filed: 2018-04-11
Granted: 2020-06-11
Abstract: A method and a device for detecting an active power of a wind turbine. The method includes: acquiring a current rotation speed of a rotor of a wind power generator of a wind 5 turbine and a current outputted active power; determining an effective wind speed of the wind turbine, based on the current rotation speed and the current outputted active power; determining a maximum active power capable to be captured by the wind turbine at the current rotation speed, based on the effective wind speed and a maximum utilization-rate coefficient for wind energy of the wind turbine at the current rotation speed; determining a 10 maximum active power capable to be outputted by the wind turbine, based on the maximum active power capable to be captured and a corresponding power loss, and determining a release power at which the wind turbine is capable to release a rotation kinetic energy of the wind turbine for a predetermined time at the current rotation speed; and determining the available active power of the wind turbine, based on the maximum active power capable to be 15 outputted, the release power, and the current outputted active power.
Patent AU-2018373532-B2 (AU)
Title: Herbicidal phenylethers
Inventor: WITSCHEL MATTHIAS
IPC: C07D401/12
Filed: 2018-11-12
Granted: 2023-02-16
Abstract: The present invention relates to phenylethers of formula (I) or their agriculturally acceptable salts or derivatives, wherein the variables are defined according to the description, processes and intermediates for preparing the phenylethers of formula (I), compositions comprising them and their use as herbicides, i.e. for controlling harmful plants, and also a method for controlling unwanted vegetation which comprises allowing a herbicidal effective amount of at least one phenylether of formula (I) to act on plants, their seed and/or their habitat.
Patent AU-2018376566-B2 (AU)
Title: Process and device for preparing a solid dispersion
Inventor: ADAGE TIZIANA
IPC: A61K9/16
Filed: 2018-11-29
Granted: 2023-11-30
Abstract: The present invention relates to a melt extrusion process for preparing a solid dispersion comprising a pharmaceutically active ingredient, a polymeric binder, and, optionally, one or more auxiliary agents, comprising a) in a batch-wise operation, placing a pre-determined amount of the polymeric binder, a pre-determined amount of the active ingredient, and, optionally, a pre-determined amount of the auxiliary agent(s) in a melting vessel; melting the polymeric binder with agitation to disperse the active ingredient in the polymeric binder to obtain a molten pre-dispersion; b) feeding the pre-dispersion into an extruder to homogenize the pre-dispersion and release a melt through a die; and c) allowing the melt to solidify.
Patent AU-2018396877-B2 (AU)
Title: Anti-LAG3 antibody and uses thereof
Inventor: MIAO XIAONIU
IPC: A61P35/00
Filed: 2018-12-27
Granted: 2022-02-03
Abstract: The present invention relates to new-type antibodies and antibody fragments that specifically bind to LAG-3 and compositions containing the antibodies or antibody fragments. Furthermore, the present invention relates to nucleic acids encoding the antibodies or antibody fragments thereof, and host cells comprising the antibodies or antibody fragments thereof, and related uses. Furthermore, the present invention relates to the therapeutic and diagnostic uses of these antibodies and antibody fragments. In particular, the present invention relates to therapy combining these antibodies and antibody fragments with other therapeutic agents, such as anti-PD-1 or anti-PD-L1 antibodies.
Patent AU-2019201727-B2 (AU)
Title: Cartridge receiver, cartridge system, drink preparation machine and method for producing a drink
Inventor: KRÜGER MARC
IPC: B67D1/08
Filed: 2019-03-13
Granted: 2021-05-27
Abstract: The invention relates to a cartridge system (1) for producing a drinkinadrink preparation 
machine, comprising a cartridge (2) that has a reservoir (6) filled with a drink substance (7), 
and a cartridge receiver (10) that can be reversibly connected to the cartridge, said cartridge 
receiver (10) comprising a mixing chamber (8) and a cartridge discharge device (34) which 
causes at least partial transfer of the drink substance (7) from the reservoir (6) into the 
mixing chamber (8), and said cartridge receiver (10) comprising a fluid supply (12) which 
opens into the mixing chamber (8). The invention also relates to the cartridge receiver (10) 
of the cartridge system (1), the drink preparation machine, and the corresponding method for 
producing a drink (70).
WO 2017/121802 PCT/EP2017/050567 
2/4 
20 22 
516 
526451 
646 
24 
642 
10 101 10 1 
Fig.3a 1 Fig.3b 1 Fig.3cf
Patent AU-2019203204-B2 (AU)
Title: Vertical takeoff and landing (VTOL) air vehicle
Inventor: TAYLOR DANA J
IPC: B64C25/00
Filed: 2019-05-07
Granted: 2021-09-16
Abstract: A flight control apparatus for fixed-wing aircraft includes a first port wing (115) and first 
starboard wing (120), a first port swash plate (145) coupled between a first port rotor 155) 
and first port electric motor (135), the first port electric 5 motor (135) coupled to the first port 
5 wing (115), and a first starboard swash plate (150) coupled between a first starboard rotor 
(130) and first starboard electric motor (140), the first starboard electric motor (140) coupled 
to the first starboard wing (120).
WO 2015/012935 PCT/US2014/036863 
1/13 
//V 
CKz C-z 
C'7 
/n 
/o 
/n 
Cn/
Patent AU-2019204355-B2 (AU)
Title: Medical balloon devices and methods
Inventor: GOEPFRICH JAMES L
IPC: A61M25/10
Filed: 2019-06-20
Granted: 2020-05-14
Abstract: A medical balloon cover having a longitudinal axis comprising: a balloon cover comprising at least one expanded fluoropolymer material; wherein said expanded fluoropolymer material comprises a plurality of serpentine fibrils; wherein the balloon cover is wrapped at a delivery diameter, the balloon cover being substantially wrinkle free at the delivery diameter; and wherein the balloon cover has a nominal diameter that is at least 3 times greater than the delivery diameter of the balloon cover upon expansion by a balloon. 11456836_1 (GHMatters) P100119.AU.2 C
Patent AU-2019265346-B2 (AU)
Title: Heteroaryl compounds and uses thereof
Inventor: JANG MING-KUEI
IPC: C09K19/34
Filed: 2019-05-09
Granted: 2022-06-16
Abstract: Described herein are compounds of formula (I), and pharmaceutically acceptable salts, solvates, hydrates, isotopically labeled derivatives and radiolabeled derivative thereof, and pharmaceutical compositions thereof. Also provided are methods and kits involving the inventive compounds or compositions for detecting and imaging Tau aggregates in the brain for detection of Alzheimer's disease (AD) in a subject.
Patent AU-2019290163-B2 (AU)
Title: PCSK9 antagonist compounds
Inventor: WOOD HAROLD B
IPC: C12N9/64
Filed: 2019-06-20
Granted: 2022-08-04
Abstract: Disclosed are compounds of Formula I, or a salt thereof: where A, B, D, X, R1, R2 and R8 are as defined herein, which compounds have properties for antagonizing PCSK9. Also described are pharmaceutical formulations comprising the compounds of Formula I or their salts, and methods of treating cardiovascular disease and conditions related to PCSK9 activity, e.g. atherosclerosis, hypercholesterolemia, coronary heart disease, metabolic syndrome, acute coronary syndrome, or related cardiovascular disease and cardiometabolic conditions.
Patent AU-2019358314-B2 (AU)
Title: Process for preparing a coated glass substrate
Inventor: RAISBECK DEBORAH
IPC: C03C17/34
Filed: 2019-10-08
Granted: 2023-12-21
Abstract: A chemical vapour deposition process for preparing a coated glass substrate, said process comprising at least the following steps in sequence: a) providing a glass substrate having a surface, b) depositing a layer based on SiCO and/or SiNO on the surface of the glass substrate, c) exposing the layer based on SiCO and/or SiNO to a gaseous mixture (i) comprising water, and d) subsequently depositing a layer based on a TCO over the layer based on SiCO and/or SiNO.
Patent AU-2020200340-B2 (AU)
Title: Cross Product Enhanced Subband Block Based Harmonic Transposition
Inventor: VILLEMOES LARS
IPC: G10L21/038
Filed: 2020-01-17
Granted: 2020-10-15
Abstract: The invention is directed to a system configured to generate a time stretched and/or frequency 
transposed signal from an input signal. The system comprises an analysis filter bank configured to 
derive a number Y > 1 of analysis subband signals from the input signal, wherein each analysis 
subband signal comprises a plurality of complex-valued analysis samples, each having a phase and a 
magnitude; a subband processing unit configured to generate a synthesis subband signal from the Y 
analysis subband signals using a subband transposition factor Q and a subband stretch factor S, at 
least one of Q and S being greater than one, the subband processing unit comprises a block extractor 
configured to i) form Y frames of L input samples, each frame being extracted from said plurality of 
complex-valued analysis samples in an analysis subband signal and the frame length being L > 1; and 
ii) apply a block hop size of h samples to said plurality of analysis samples, prior to forming a 
subsequent frame of L input samples, thereby generating a sequence of frames of input samples; a 
nonlinear frame processing unit configured to generate, on the basis of Y corresponding frames of 
input samples formed by the block extractor, a frame of processed samples by determining a phase 
and magnitude for each processed sample of the frame, wherein, for at least one processed sample: i) 
the phase of the processed sample is based on the respective phases of the corresponding input sample 
in each of the Y frames of input samples; and ii) the magnitude of the processed sample is determined 
as a mean value of the magnitude of the corresponding input sample in a first frame of the Y frames 
of input samples and the magnitude of the corresponding input sample in a second frame of the Y 
frames of input samples; and an overlap and add unit configured to determine the synthesis subband 
signal by overlapping and adding the samples of a sequence of frames of processed samples. The 
system further comprises a synthesis filter bank configured to generate the time stretched and/or 
frequency transposed signal from the synthesis subband signal, wherein the system is operable at least 
for Y= 2.
Patent AU-2020201348-B2 (AU)
Title: Autonomous condensing of pallets of items in a warehouse
Inventor: Hance Christopher
IPC: B25J9/16
Filed: 2020-02-25
Granted: 2021-04-22
Abstract: AUTONOMOUS CONDENSING OF PALLETS OF ITEMS IN A 
WAREHOUSE 
ABSTRACT 
Examples described may enable consolidating pallets of items in a warehouse. An 
example method includes determining an expected amount of time for at least one robotic 
device positioned in a warehouse to condense items on a group of two or more pallets into a 
single pallet; based on the expected amount of time, scheduling a condensing time at which to 
cause the at least one robotic device to condense the items on the group of two or more pallets 
into the single pallet; and controlling the at least one robotic device to condense the items on the 
group of two or more pallets into the single pallet at the scheduled condensing time.
Patent AU-2020202394-B2 (AU)
Title: Novel chimeric insecticidal proteins toxic or inhibitory to lepidopteran pests
Inventor: BAUM JAMES A
IPC: C07K14/325
Filed: 2020-04-05
Granted: 2020-10-01
Abstract: Nucleotide sequences are disclosed that encode novel chimeric insecticidal proteins 
exhibiting Lepidopteran inhibitory activity. Particular embodiments provide compositions and 
transformed plants, plant parts, and seeds containing the recombinant nucleic acid molecules 
encoding one or more of the chimeric insecticidal proteins.
Patent AU-2020202860-B2 (AU)
Title: Flip open catheter package
Inventor: HANNON DAVID
IPC: B65D85/00
Filed: 2020-04-30
Granted: 2022-01-27
Abstract: A catheter package includes an elongated case. A cap is attached to the case by a flexible 
strap. The case receives the tubing portion of a catheter. The catheter has a funnel 
attached to the tubing. The funnel has a seal portion releasably engageable with the case.  
The cap is releasably engageable with the funnel to retain the funnel in contact with the 
case. A user can flip the cap off the funnel to permit removal of the catheter from the case.  
The funnel may include ridges or a tactile ring to improve the user's grip on the funnel. An 
adaptor may be disposed between the funnel and case to allow mating of different cross 
sectional shapes of the funnel and case. A hydration device may be inserted in the case.  
Alternately, a tubular liner may be inserted in the case to separate liquid water on the outside 
of the liner from the catheter tubing on the inside of the liner. A window in the liner mounts a 
patch of filter material that permits the passage of water vapor into the interior of the liner.  
FIG. 30
17/25 
218 
220 
214 218 
224 220 
21 
2084 
2121 
208 Fig. 30 
222 
208 
210 
Fig. 31
Patent AU-2020202868-B2 (AU)
Title: Method of implantation of cell aggregates and tissue fragments
Inventor: SCHOUENBORG JENS
IPC: A61N1/05
Filed: 2020-04-30
Granted: 2022-08-04
Abstract: In a method for implantation of a physically stabilized aggregate of living cells or 
tissue fragment is injected into a channel provided in soft tissue filled with an aqueous gel.  
Also discloses are methods of stabilizing such aggregates and fragments and of forming 
such channel in soft tissue as well as means for carrying out the methods.
Patent AU-2020230284-B2 (AU)
Title: Superconducting circuit structure, superconducting quantum chip and superconducting quantum computer
Inventor: JIN LIJING
IPC: G06N10/00
Filed: 2020-09-10
Granted: 2021-11-04
Abstract: A superconducting circuit structure, a superconducting quantum chip, and a superconducting 
quantum computer are provided according to embodiments of the application, which relate to the 
field of quantum computing. The superconducting circuit structure includes: at least two qubits; a 
5 connector, coupled with the two qubits respectively, to realize transversal coupling with each of the 
two qubits; and a coupler, coupled with the two qubits respectively, to realize longitudinal coupling 
with each of the two qubits. Therefore, the azaz parasitic coupling between the qubits is effectively 
removed, and a two-qubit gate with high fidelity is obtained.  
0 (FIG. 1) 
21
1/2 
N. coupler 
IGI 
qubit q,   qubit q2 
second second 
capacitor capacitor 
Josephson junction 
i -- - -- - -- - - - - - - - - - - -- - - - - - - - - - - - In 
ff 
_EA .I 
[X I IA 
X I 
................. ................ m .. ...........  
I ;*--y-------p--r 
FIG 2
Patent AU-2020250404-B2 (AU)
Title: Premixed Combustion Burner
Inventor: UCHIYAMA YUTA
IPC: F23D14/78
Filed: 2020-03-25
Granted: 2023-01-05
Abstract: This premixing combustion burner is provided with: a mixing part that has a first peripheral wall centered on the burner axial line, a mixing region formed on the inner periphery thereof for mixing a gas fuel and air, and a plurality of air supply ports arranged side by side in the peripheral direction and open in the first peripheral wall; a nozzle part that is provided to the tip side of the mixing part and that has a second peripheral wall centered on the burner axial line, a premixed gas passage connected to the mixing region and formed in the inner periphery of the second peripheral wall, and a cooling passage formed in the second peripheral wall; and a header part that is provided to the base end side of the mixing part and that has formed therein a first header chamber, a fuel supply port for supplying a gas fuel to the first header chamber, a second header chamber, and a fuel injection port communicating with the second header chamber and the mixing region. In the first peripheral wall, a forward route that connects the first header chamber and the inlet of the cooling passage, and a backward route that connects the outlet of the cooling passage and the second header chamber are formed.
Patent AU-2020254442-B2 (AU)
Title: Cosmetic material and production method for cosmetic material
Inventor: USUI HIRONAGA
IPC: B44C1/20
Filed: 2020-03-17
Granted: 2023-09-07
Abstract: Provided is a high-design cosmetic material that can impart an excellent sense of three-dimensionality and has shading that varies widely by observation angle.　A cosmetic material in which a plurality of independent closed regions that have a grooved parallel recess and protrusion pattern are provided on a first principal surface side. The depth of the recesses of the grooved parallel recess and protrusion pattern of at least a portion of the closed regions changes within the closed regions, and the recesses of the grooved parallel recess and protrusion pattern within each closed region are at least partially filled with a colorant in the depth direction.
Patent AU-2020294224-B2 (AU)
Title: Photo-controlled removal of targets in vitro and in vivo
Inventor: KOBAYASHI HISATAKA
IPC: A61K41/00
Filed: 2020-12-23
Granted: 2022-10-27
Abstract: OF THE DISCLOSURE 
This disclosure provides IR700-molecule conjugates and methods of their use to remove 
(e.g., separate or isolate) a target from a sample in vivo or from a subject in vitro. It is shown 
herein that exposure of IR700 to near infrared (NIR) light removes a portion of IR700, changing it 
from a hydrophilic molecule, to one that is hydrophobic, resulting in aggregation of IR700 and 
anything bound to it. For example, the disclosed IR700-molecule conjugates and methods provide 
photo-controlled ways to control the pharmacokinetics of a drug in vivo, and can be used to remove 
undesired agents from environmental or food samples or to isolate target molecules in a laboratory.
Patent AU-2021203155-B2 (AU)
Title: Simultaneous quantification of a plurality of proteins in a user-defined region of a cross-sectioned tissue
Inventor: BEECHEM JOSEPH M
IPC: G01N33/68
Filed: 2021-05-17
Granted: 2022-06-30
Abstract: The present invention relates to, among other things, probes, compositions, methods, and kits for 
simultaneous, multiplexed detection and quantification of protein expression in a user-defined 
region of a tissue, user-defined cell, and/or user-defined subcellular structure within a cell.
Patent AU-2021204533-B2 (AU)
Title: Dual lumen sheath for arterial access
Inventor: CORBETT SCOTT C
IPC: A61M60/135
Filed: 2021-06-30
Granted: 2023-08-31
Abstract: [0051] A sheath assembly for the insertion of a percutaneous pump includes a tubular sheath 
body dimensioned for insertion into a blood vessel through a vessel aperture. The tubular 
sheath body includes a wall having a proximal end portion, a distal end portion, a 
5 longitudinal axis, an outer surface, an inner surface defining a first lumen substantially 
parallel to the longitudinal axis, and a second lumen disposed within the wall between the 
inner surface and the outer surface and extending from the proximal end portion to the distal 
end portion. The first lumen is dimensioned to allow passage of a portion of the 
percutaneous pump, and the second lumen is dimensioned for passage of a guidewire. A 
0 stylet is removably positioned to substantially occlude the second lumen. The stylet has a 
proximal end releasably secured to the sheath assembly.
Patent JP-3914690-B2 (JP)
IPC: H01L21/677
Filed: 2000-06-16
Granted: 2007-05-16
Abstract: PROBLEM TO BE SOLVED: To precisely control time until an exposed substrate is heat-treated and to form an uniform line width. SOLUTION: In an interface part 5, a transfer device 110 is arranged so that it faces a second cooling processor group 80 in a processing station 3, a heat processor group 112 where heat treatment devices are arranged in multiple stages is arranged in one side so that the transfer device 110 is interposed therebetween, and peripheral exposure equipment, a buffer cassette and a wafer- holding part 115 are successively arranged in lamination on the other side from the top. A secondary transfer body 116 is arranged between the wafer holding part 115 and an exposure device 4, and a wafer W is carried in/out between an in-stage 401 and an out-stage 402 in the exposure device 4 through the body 116.
Patent JP-3285343-B2 (JP)
IPC: C07D498/04
Filed: 2000-08-30
Granted: 2002-05-27
Abstract: The present invention relates to tetrahydroquinazoline-2,4-diones derivatives of the formula (I):  <CHEM>  pharmaceutically acceptable salts thereof, wherein A is (CH2)n where n is equal to 0, 1 or 2; U is CH2, NH, or NR<3>, R<1> and R<2> are selected independently from H, (C1-C6)alkyl, Cl, F, CN, nitro, CF3, -NHC(O)R<6> and -OR<7>, or R<1> and R<2>, together with the atoms to which they are attached, form a carbocyclic or heterocyclic five- or six-membered ring, R<3> is selected from the group consisting of H, (C1-C6)malkyl, C(=O)-(C1-C6)alkyl, where m=1 or 2; R<4> and R<5> are selected from H, (C1-C6)alkyl, Cl, F,-CF3, -CN, -NHC(=O)R<6>, -OR, a 5-to 7-membered aryl or heteroaryl ring, where m, R<6> and R<7> are as defined above; and R<6> and R<7> are selected independently from H, (C1-C6)alkyl or a 5- to 7-membered aryl or heteroaryl ring; V is CH, CR<3>, or N; W is CH2, C(O), or S(O)2; X is C or N; and Y is CH, CR<1>, CR<2>, or N. The invention also relates to pharmaceutical compositions containing the same and to methods of use thereof, including in the inhibition of serotonin reuptake, the inhibition of the binding of 5-HT2A serotonin receptors and the treatment of diseases, conditions or disorders of the central nervous system. Further, the present invention is also directed to methods for the preparation of 4-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)-propyl-1,2,3,4-tetrahydroq uinazoline-2,4-dione compounds and intermediates useful therefor.
Patent JP-3383795-B2 (JP)
IPC: C12N15/11
Filed: 2000-09-06
Granted: 2003-03-04
Abstract: Recombinant, in particular humanised, e.g. humanised chimeric and CDR-grafted humanised, antibody molecules having specificity for human TNF alpha , are provided for use in diagnosis and therapy. In particular the antibody molecules have antigen binding sites derived from murine monoclonal antibodies CB0006, CB010, hTNF3 or 101.4. Preferred CDR-grafted humanised anti-hTNF alpha  antibodies comprise variable region domains comprising human acceptor framework and donor antigen binding regions and wherein the frameworks comprise donor residues at specific positions. The antibody molecules may be used for therapeutic treatment of human patients suffering from or at risk of disorders associated with undesirably high levels of TNF, in particular for treatment of immunoregulatory and inflammatory disorders or of septic, endotoxic or cardiovascular shock. <IMAGE>